News and Press Releases

Life Sciences organizations expect more than one-fifth of revenue to come from connected health in the next five years

Sixfold increase in biopharma organizations with market-ready connected health products since 2021; three in four medtech organizations already have connected health products on the market June 18 2024 - Paris,...

Category: Biotechnology, Other
Posted: June 18, 2024

UK Head Office, Capgemini Services, 40 Holborn Viaduct, London, EC1N 2PB

Swixx Biopharma Expands to Latin America Through a Strategic Acquisition and Combination with Biopas 

With the addition of $220m in sales, over 300 employees and therapeutic coverage in Neurology, Oncology, Immunology, Gastroenterology, Rare Diseases and Specialty, acquisition extends and transforms Swixx BioPharma’s footprint The...

Category: Other, Pharmaceutical
Posted: May 22, 2024

Neuhofstrasse 5A CH-6340 Baar Switzerland

Myonex Closes Creapharm Acquisition Expanding Global Services

2 May 2024 -- Pennsylvania, US -- Myonex has completed the previously announced acquisition of Creapharm’s pharmaceutical services business. This transaction combines capabilities and flexibility to serve pharmaceutical and biotech...

Category: Biotechnology, Pharmaceutical
Posted: May 2, 2024

100 Progress Dr., Horsham, PA 19044

Bios Health Group Unveils Bios Innovation Circle

Ground-breaking venture studio and strategic hub empowers members with comprehensive arsenal of benefits to dominate the life sciences arena 9 April 2024 -- Georgia, US -- Bios Health Group, a...

Category: Biotechnology, Pharmaceutical
Posted: April 9, 2024

3235 Satellite Blvd #300 Duluth GA 30096 USA

Myonex Announces Acquisition of Safeway Compounding Pharmacy to Expand its Clinical Trial Services Across the US

9 April 2024  -- Horsham, US -- Myonex, a leading global clinical trial supply company, has completed the acquisition of SaveWay Compounding Pharmacy of Newark, US. The pharmacy will operate as...

Category: Clinical Trials
Posted: April 9, 2024

100 Progress Dr., Horsham, PA 19044

Bora Pharmaceuticals completes the acquisition of Upsher-Smith

Acquisition expands Bora’s North American footprint with first US manufacturing site  1 April 2024 -- Taipei, Taiwan -- Bora Pharmaceuticals today announced that it has completed the acquisition of Upsher-Smith Laboratories,...

Category: BioManufacturing
Posted: April 1, 2024

6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd., Neihu District, Taipei City, 114 Taiwan

Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy

27 March 2024 -- Princeton, US, and Frankfurt, Germany -- Indegene, a digital-first, life sciences commercialisation company, announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy), a global provider...

Category: Pharmaceutical
Posted: March 27, 2024

Indegene, Inc. 150 College Rd W Suite 104 Princeton NJ 08540

Novo Nordisk to acquire Cardior Pharmaceuticals and strengthenpipeline in cardiovascular disease

25 March, 2024 -- Bagsværd, Denmark, and Hannover, Germany -- Novo Nordisk and CardiorPharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to€1.025bn, including an upfront...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: March 26, 2024

Novo Nordisk A/S Novo Allé, 2880 Bagsvaerd Denmark

FGK Clinical Research GmbH Acquires Clinicology Ltd, Expanding Territorial Footprint in Europe

22 February 2024 -- Munich, Germany -- FGK Clinical Research GmbH, a European-based full-service provider of clinical research services, is thrilled to announce the successful acquisition of Clinicology Ltd, a...

Category: Clinical Trials
Posted: February 22, 2024

Heimeranstrasse 35 80339 Munich, Germany

Greenphire Announces Acquisition of Clincierge to Enhance Clinical Trial Support Services

Addition enables sponsors to solve the number one clinical trial participant obstacle – transportation, with a single industry-leading solution 1 February 2024 -- Pennsylvania, US -- Greenphire, a leading innovator in...

Category: Clinical Trials
Posted: February 1, 2024

1018 W. 9th Avenue, Suite 200 King of Prussia, PA 19406

Calypso Enters into Agreement to Be Acquired by Novartis

Calypso is a European biotech translating Interleukin-15 biology into medical breakthroughs by developing CALY-002, an anti-IL-15 monoclonal antibody, for an array of autoimmune indications The acquisition of Calypso gives Novartis...

Category: Biotechnology
Posted: January 8, 2024

Gustav Mahlerplein 102 1082 MA Amsterdam The Netherlands

Start Codon Invites Life Sciences Leaders, Founders, and Investors to Innovation Showcase 2023

Hybrid event is taking place 10 October 2023, in Cambridge, UK Programme features presentations from five disruptive portfolio companies and networking opportunities with Start Codon’s extended portfolio Registration for Innovation...

Category: Other
Posted: September 26, 2023

c/o Milner Therapeutics Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge Biomedical Campus, Cambridge CB2 0AW